Diagnostic and Monitoring Ophthalmic Devices and Equipment Market Report 2025

This Diagnostic and Monitoring Ophthalmic Devices and Equipment market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The diagnostic and monitoring ophthalmic devices and equipment market size has grown strongly in recent years. It will grow from $5.22 billion in 2024 to $5.63 billion in 2025 at a compound annual growth rate (CAGR) of 7.8%. The growth in the historic period can be attributed to aging population, advances in ophthalmic imaging, prevalence of eye diseases, diabetes epidemic.

The diagnostic and monitoring ophthalmic devices and equipment market size is expected to see steady growth in the next few years. It will grow to $6.78 billion in 2029 at a compound annual growth rate (CAGR) of 4.8%. The growth in the forecast period can be attributed to emerging markets growth, telemedicine and teleophthalmology, value-based healthcare, regulatory support and reimbursement. Major trends in the forecast period include artificial intelligence (ai) integration, portable and handheld devices, home monitoring solutions, 3d and wide-field imaging.

The rising incidence of diabetes is expected to drive the growth of diagnostic and monitoring equipment within the ophthalmic devices market. Diabetes is a chronic condition that occurs when the body is unable to effectively use or produce enough insulin, a hormone that regulates blood sugar levels. Diagnostic and monitoring tools in ophthalmic devices, such as smart contact lenses, can serve both continuous glucose monitoring and diabetic retinopathy treatment. These devices wirelessly track glucose levels and provide real-time data to users. For example, in March 2024, the Office for Health Improvement & Disparities, a UK-based government department, reported that between March 2022 and March 2023, the percentage of individuals with type 1 diabetes receiving all eight recommended care processes increased by 22%, while for type 2 diabetes, the increase was 21%. Additionally, the percentage of individuals achieving target HbA1c levels rose to 37.9%, the highest ever reported by the National Diabetes Audit (NDA). This growing trend in diabetes management is fueling the demand for diagnostic and monitoring equipment in the ophthalmic devices market.

The escalating prevalence of eye diseases is anticipated to propel the demand for diagnostic and monitoring equipment within the ophthalmic devices industry. Surgeries related to various eye disorders such as cataracts, diabetic retinopathy, and glaucoma have led to an increased need for diagnostic and monitoring tools in this sector. For example, according to the World Health Organization's findings in October 2022, over 2.2 billion individuals worldwide suffer from either near or distance vision problems. Of these cases, roughly half, amounting to 1 billion, encompass preventable or untreated vision loss, including various conditions such as untreated presbyopia, distance vision impairment, and cataracts, which stand as a leading cause of blindness. Hence, the expanding occurrence of eye diseases is a significant driver behind the growth of the diagnostic and monitoring ophthalmic devices and equipment market.

Major companies within the diagnostic and monitoring equipment segment of the ophthalmic devices market are focused on developing innovative solutions, such as the utilization of Smart contact lenses employing smart soft contact lens technology to enhance patient care. The use of smart soft contact lens technology is a recent advancement that allows for continuous monitoring of intraocular pressure (IOP) over a 24-hour period, particularly beneficial in glaucoma care. In January 2023, BVS Sight Inc., a US-based company, introduced Smart contact lenses using smart soft contact lens technology. These smart soft contact lenses are integrated with various existing commercial soft contact lens brands, preserving their essential properties, including lens power, biocompatibility, softness, transparency, wettability, oxygen transmissibility, and the ability for overnight wear.

Cutting-edge ophthalmic diagnostic and monitoring equipment, integrating artificial intelligence (AI) and machine learning (ML), represent the latest trends in advanced eye care medical devices. These technologies are designed to swiftly and accurately interpret patient eye conditions and recommend suitable treatments. For instance, Deepmind, a subsidiary of Alphabet Inc., has devised an AI-based system proficient in analyzing 3D retinal OCT scans. This system has demonstrated capabilities in detecting severe conditions such as glaucoma, retinopathy, macular degeneration, and around 50 different eye diseases at their early stages.

In November 2022, Alcon, a Swiss-based ophthalmology company, successfully finalized the acquisition of Aerie Pharmaceuticals for an undisclosed sum. This acquisition allows Alcon to expand its portfolio with commercial products like Rocklatan and Rhopressa, alongside a range of potential ophthalmic pharmaceutical products in the development pipeline. Aerie Pharmaceuticals, based in the United States, specializes in the field of ophthalmic pharmaceuticals.

Diagnostic and monitoring ophthalmic devices and equipment play a crucial role in the diagnosis and ongoing observation of retinal and corneal conditions, aiding in measuring refraction errors, identifying intraocular lenses (IOLs), and assessing the visual field.

Key product types in this segment include a range of equipment such as optical coherence tomographers, ophthalmic ultrasound imaging systems, fundus cameras, ophthalmoscopes, keratometers, specular microscopes, tonometers, slit lamps, retinoscopes, and others (including dioptometers, optotype projectors, perimeters, biometers, pachymeters, autorefractors/phoropters, corneal topographers, wavefront aberrometers). Fundus cameras are instrumental in rear-eye imaging for diagnostic and monitoring purposes, contributing significantly to applications like retinal evaluation, glaucoma detection and monitoring, surgical evaluations, general examinations, intraoperative devices, and refraction equipment. These ophthalmic devices are utilized across various settings, including hospitals, clinics, diagnostic laboratories, and research centers.

The diagnostic and monitoring ophthalmic devices and equipment market research report is one of a series of new reports that provides diagnostic and monitoring ophthalmic devices and equipment market statistics, including diagnostic and monitoring ophthalmic devices and equipment industry global market size, regional shares, competitors with a diagnostic and monitoring ophthalmic devices and equipment market share, detailed diagnostic and monitoring ophthalmic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic and monitoring ophthalmic devices and equipment industry. This diagnostic and monitoring ophthalmic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Major companies operating in the diagnostic and monitoring ophthalmic devices and equipment market include Carl Zeiss Meditec, Alcon Inc., Bausch + Lomb, Haag-Streit, Topcon Corporation, Nidek Co. Ltd., Abbott Medical Optics, Johnson and Johnson Vision Care, Essilor International S.A, Ziemer Ophthalmic Systems AG, STAAR Surgical Company, Ellex, Quantel Medical Inc, Optovue, Canon Inc., Halma plc, Coburn Technologies Inc., Kowa Company Ltd., AMETEK Inc., AbbVie Inc., Hoya Corporation, Ridex Corporation, CIBA Vision Corporation, CooperVision, Gulden Ophthalmics, Glaukos Corporation, FCI Ophthalmics, Matronix India Corporation, HEINE Optotechnik, Visionix Ltd., Neo Vision, Clear Lab, Appasamy Associates, Ophtec BV, Lumenis, Intuvision Labs, Ocular Instruments, Ophthalmic Instruments Company, Keeler Ltd., Oculus, Reichert Technologies, Tomey Corporation, US Ophthalmic.

North America was the largest region in the global diagnostic and monitoring ophthalmic devices and equipment market in 2024. Asia-Pacific was the second-largest region in diagnostic and monitoring ophthalmic devices and equipment market. The regions covered in the diagnostic and monitoring ophthalmic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the diagnostic and monitoring ophthalmic devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The Diagnostic and monitoring ophthalmic devices and equipment market consist of sales of ultrasound imaging systems ophthalmoscopes, corneal topographers, specular microscopes, slit lamps, fundus cameras, anomaloscope, haploscope, ophthalmic lens gauge, stereopsis measuring Instrument, retinoscopes, stereoscope, and others that are used for diagnosis and monitoring of ophthalmic diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.